A clinical formulation indicated for Autoimmune Care and Skin Care. This option manages hyper-active immune responses in dermal tissues to lower inflammation and soothe persistent irritation.
A topical immunomodulator intended to manage moderate to severe eczema and designed to alleviate skin inflammation to support healing without using steroids.
Mechanism of Action
It inhibits calcineurin, which blocks the activation of T-cells. This suppresses the overactive immune response in the skin that causes itching and inflammation.
Route of Administration
Topical
Onset Time
1–3 weeks
Duration
N/A
Contraindications
Allergy to tacrolimus, Weakened immune system, Active skin infections
Severe Adverse Events
Severe skin reaction, Lymphoma risk (unconfirmed caution), Skin cancer risk (caution), Lymphadenopathy
Common Side Effects
Skin stinging, Burning sensation, Itching
Uncommon Side Effects
Redness, Flu-like symptoms, Folliculitis, Increased sensitivity to heat
Drug Interactions
Ketoconazole, Cimetidine
Pregnancy Safety Warnings
Use only if benefit outweigh risk.
Age Restrictions
0.03% for children 2+; 0.1% for adults only.
Storage Guidelines
Store at room temperature. Avoid sunlight on treated areas.
Information for Tacrolimus is sourced from established medical standards and updated frequently. It is provided for general reference and should be confirmed with a healthcare professional before use.
